VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 126 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.13 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |
| Kynam Capital Management, LP | 699,681 | $10,733,107 | 1.76% |
| Deep Track Capital, LP | 2,963,267 | $45,456,516 | 1.76% |
| TANG CAPITAL MANAGEMENT LLC | 669,125 | $10,264,378 | 1.45% |
| Ghost Tree Capital, LLC | 275,000 | $4,218,500 | 1.39% |
| MPM BioImpact LLC | 255,323 | $3,916,655 | 1.05% |
| Yiheng Capital Management, L.P. | 1,228,534 | $18,845,712 | 0.96% |
| BRAIDWELL LP | 1,735,182 | $26,617,692 | 0.84% |
| HighVista Strategies LLC | 104,756 | $1,606,957 | 0.74% |
| AlphaCentric Advisors LLC | 80,000 | $1,227,200 | 0.70% |
| RA Capital Management | 2,007,946 | $30,801,892 | 0.61% |
External links
This page lists VIRIDIAN THERAPEUTICS INC's shareholders in Q3 2023. To view VIRIDIAN THERAPEUTICS INC's shareholder history, click here.